Home/Immatics Biotechnologies/Peter Chambré

PC

Peter Chambré

Chairman of the Board of Directors

Immatics Biotechnologies

Roles

Chairman of the Board of DirectorsatImmatics Biotechnologies

Chairman of the Board of DirectorsatImmatics

Therapeutic Areas

Oncology Solid Tumors

Immatics Biotechnologies Pipeline

Drug	Indication	Phase
IMA203	PRAME-positive solid tumors	Phase 1/2
IMA203CD8	PRAME-positive solid tumors	Phase 1/2
IMA402	PRAME-positive solid tumors	Phase 1/2
IMA204	Undisclosed solid tumors	Phase 1

Leadership Team at Immatics Biotechnologies

Harpreet Singh, Ph.D.

Chief Executive Officer

Cedrik Britten, M.D.

Chief Medical Officer

Carsten Reinhardt, M.D., Ph.D.

Chief Development Officer

Steffen Walter, Ph.D.

Chief Operating Officer

Toni Weinschenk, Ph.D.

Chief Innovation Officer

Venkat Ramanan, Ph.D.

Chief Financial Officer

Rainer Kramer, Ph.D.

Chief Business Officer & Site Head Munich

Edward Sturchio, J.D.

General Counsel

Heather L. Mason

Vice Chair of the Board of Directors

View full Immatics Biotechnologies profile